Access in all areas? A round-up of developments in market access and health technology assessment: part 12

In this update we cover the impacts of the US Most Favored Nation pricing policy and research evaluating drug availability and affordability in China as a result of the National Reimbursement Drug List negotiation policy.

Authors

Institutions

Publication Details

Journal
Journal of Comparative Effectiveness Research
Published
2026-01-07
DOI
https://doi.org/10.57264/cer-2025-0208
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Access in all areas? A round-up of developments in market access and health technology assessment: part 12

S V Ramagopalan, Annie Jullien Pannelay
Journal of Comparative Effectiveness Research
Pharmaceutical Economics and Policy
article

Access in all areas? A round-up of developments in market access and health technology assessment: part 12

S V Ramagopalan, Annie Jullien Pannelay
article en

Abstract

In this update we cover the impacts of the US Most Favored Nation pricing policy and research evaluating drug availability and affordability in China as a result of the National Reimbursement Drug List negotiation policy.

Journal of Comparative Effectiveness ResearchVol. 15(2)
King's College London (GB), Université Paris-Saclay (FR)
Openalex Percentile: Top 96%
Pharmaceutical Economics and Policy
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Access in all areas? A round-up of developments in market access and health technology assessment: part 12 — S V Ramagopalan, Annie Jullien Pannelay · Journal of Comparative Effectiveness Research (2026) | TGRS Research Map | TGRS